Total Payments
$35,455
2024 Payments
$2,982
Companies
26
Transactions
286
Medicare Patients
1,391
Medicare Billing
$112,488
Payment Breakdown by Category
Other$23,500 (66.3%)
Travel$5,930 (16.7%)
Food & Beverage$5,734 (16.2%)
Education$290.98 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $23,500 | 4 | 66.3% |
| Travel and Lodging | $5,930 | 21 | 16.7% |
| Food and Beverage | $5,734 | 259 | 16.2% |
| Education | $290.98 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $12,510 | 2 | $0 (2020) |
| Abbott Laboratories | $7,306 | 102 | $0 (2024) |
| Medtronic, Inc. | $6,592 | 16 | $0 (2024) |
| Boston Scientific Corporation | $6,358 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $443.57 | 34 | $0 (2024) |
| Amgen Inc. | $407.25 | 19 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $372.45 | 23 | $0 (2024) |
| PFIZER INC. | $221.01 | 11 | $0 (2024) |
| BIOTRONIK INC. | $211.87 | 3 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $121.97 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,982 | 105 | Abbott Laboratories ($1,506) |
| 2023 | $4,761 | 103 | Abbott Laboratories ($3,675) |
| 2022 | $2,929 | 61 | Abbott Laboratories ($2,125) |
| 2021 | $11,424 | 7 | Medtronic, Inc. ($6,216) |
| 2020 | $12,510 | 2 | Medtronic Vascular, Inc. ($12,510) |
| 2019 | $773.36 | 7 | Boston Scientific Corporation ($773.36) |
| 2018 | $74.99 | 1 | AstraZeneca Pharmaceuticals LP ($74.99) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Not Applicable | ||||||
| 11/22/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/13/2024 | BIOTRONIK INC. | Selectra (Device) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $65.72 | General |
| Category: Structural Heart | ||||||
| 11/06/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: Structural Heart | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: DIABETES | ||||||
| 10/18/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.23 | General |
| 10/15/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Lithoplasty | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 09/30/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: CARDIOLOGY | ||||||
| 09/26/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,184 | 1,621 | $334,304 | $98,937 |
| 2022 | 10 | 207 | 231 | $35,113 | $13,551 |
Total Patients
1,391
Total Services
1,852
Medicare Billing
$112,488
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 200 | $43,800 | $18,675 | 42.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 22 | 22 | $47,443 | $9,079 | 19.1% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 12 | 12 | $33,576 | $9,000 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 64 | $18,880 | $8,223 | 43.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 54 | $21,789 | $7,395 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 101 | $15,150 | $6,345 | 41.9% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 18 | 18 | $19,576 | $5,241 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 50 | $14,050 | $5,152 | 36.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 97 | 133 | $15,541 | $4,153 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,064 | $3,162 | 39.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 113 | 204 | $17,748 | $3,101 | 17.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 83 | 140 | $14,420 | $2,969 | 20.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $7,999 | $2,847 | 35.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 116 | 171 | $8,550 | $1,894 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 34 | $5,100 | $1,792 | 35.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 31 | 65 | $11,830 | $1,677 | 14.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 15 | $3,195 | $1,428 | 44.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 15 | 16 | $7,344 | $1,378 | 18.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 29 | $2,407 | $1,168 | 48.5% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 13 | 17 | $3,029 | $905.40 | 29.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 74 | 119 | $3,927 | $754.18 | 19.2% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 11 | 14 | $2,726 | $736.04 | 27.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 65 | 67 | $3,494 | $700.15 | 20.0% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 12 | 15 | $1,962 | $604.35 | 30.8% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 12 | 18 | $2,704 | $557.33 | 20.6% |
About Dr. Andrew Berdy, MD
Dr. Andrew Berdy, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Belleville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1821425067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Berdy, MD has received a total of $35,455 in payments from pharmaceutical and medical device companies, with $2,982 received in 2024. These payments were reported across 286 transactions from 26 companies. The most common payment nature is "Grant" ($23,500).
As a Medicare-enrolled provider, Berdy has provided services to 1,391 Medicare beneficiaries, totaling 1,852 services with total Medicare billing of $112,488. Data is available for 2 years (2022–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Cardiovascular Disease
- Location Belleville, IL
- Active Since 10/02/2013
- Last Updated 07/06/2022
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1821425067
Products in Payments
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM (Device) $5,000
- AVEIR (Device) $4,765
- ENSITE PRECISION (Device) $1,482
- GENERAL THERAPIES (Device) $773.36
- Repatha (Biological) $407.25
- LifeVest (Device) $372.45
- LEQVIO (Drug) $248.33
- ENSITE (Device) $236.39
- ENTRESTO (Drug) $195.24
- ELIQUIS (Drug) $186.29
- General - Therapies (Device) $169.11
- WATCHMAN Access System (Device) $156.37
- COBALT DR MRI SURESCAN (Device) $155.69
- Solia (Device) $150.00
- QUARTET (Device) $134.91
- RHYTHMVIEW (Device) $126.30
- Arcalyst (Drug) $121.97
- AMPLATZER AMULET (Device) $120.19
- VYNDAQEL (Drug) $98.92
- LINQ II (Device) $93.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.